PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
82 hedge funds and large institutions have $276M invested in Aratana Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 11 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
82
Holding in Top 10
1
Calls
–
Puts
$5K
Top Buyers
| 1 | +$16.2M | |
| 2 | +$7.26M | |
| 3 | +$6.62M | |
| 4 |
Jennison Associates
New York
|
+$6.41M |
| 5 |
BC
Broadfin Capital
New York
|
+$6.27M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$8.88M | |
| 3 | -$6.74M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$3.53M |
| 5 |
AP
Alydar Partners
Boston,
Massachusetts
|
-$2.81M |